Aspiriant LLC’s iShares MSCI EAFE Min Vol Factor ETF EFAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Sell
55,558
-299
-0.5% -$27.1K 0.12% 75
2026
Q1
$5.1M Sell
55,857
-9,821
-15% -$887K 0.15% 68
2025
Q4
$5.66M Sell
65,678
-11,203
-15% -$958K 0.16% 67
2025
Q3
$6.52M Sell
76,881
-1,830
-2% -$154K 0.2% 54
2025
Q2
$6.62M Sell
78,711
-7,974
-9% -$653K 0.21% 54
2025
Q1
$6.75M Sell
86,685
-41,236
-32% -$3.08M 0.23% 45
2024
Q4
$9.05M Sell
127,921
-3,469
-3% -$255K 0.33% 41
2024
Q3
$10.1M Sell
131,390
-1,782
-1% -$132K 0.38% 36
2024
Q2
$9.24M Sell
133,172
-8,955
-6% -$629K 0.38% 36
2024
Q1
$10.1M Sell
142,127
-14,006
-9% -$974K 0.42% 34
2023
Q4
$10.8M Sell
156,133
-4,709
-3% -$312K 0.49% 32
2023
Q3
$10.5M Sell
160,842
-9,841
-6% -$661K 0.54% 30
2023
Q2
$11.5M Sell
170,683
-6,571
-4% -$453K 0.58% 28
2023
Q1
$12M Sell
177,254
-27,070
-13% -$1.78M 0.63% 26
2022
Q4
$13M Sell
204,324
-373,191
-65% -$22.8M 0.66% 26
2022
Q3
$32.9M Buy
577,515
+401,850
+229% +$25.2M 1.61% 14
2022
Q2
$11.1M Buy
175,665
+140,765
+403% +$9.46M 0.54% 28
2022
Q1
$2.52M Sell
34,900
-552
-2% -$40.1K 0.14% 75
2021
Q4
$2.72M Hold
35,452
0.15% 77
2021
Q3
$2.67M Sell
35,452
-3,905
-10% -$303K 0.16% 68
2021
Q2
$2.97M Sell
39,357
-1,341
-3% -$101K 0.17% 61
2021
Q1
$2.97M Sell
40,698
-5,949
-13% -$437K 0.19% 50
2020
Q4
$3.42M Sell
46,647
-42
-0.1% -$2.96K 0.23% 44
2020
Q3
$3.18M Sell
46,689
-33,577
-42% -$2.29M 0.25% 48
2020
Q2
$5.3M Buy
80,266
+39,953
+99% +$2.59M 0.49% 29
2020
Q1
$2.5M Sell
40,313
-13,539
-25% -$951K 0.25% 42
2019
Q4
$4.01M Buy
53,852
+2,028
+4% +$151K 0.37% 37
2019
Q3
$3.8M Sell
51,824
-2,123
-4% -$154K 0.34% 44
2019
Q2
$3.92M Buy
53,947
+547
+1% +$39.3K 0.33% 49
2019
Q1
$3.85M Sell
53,400
-27,352
-34% -$1.92M 0.31% 52
2018
Q4
$5.38M Buy
80,752
+47,389
+142% +$3.26M 0.41% 42
2018
Q3
$2.43M Buy
33,363
+1,000
+3% +$72.1K 0.21% 73
2018
Q2
$2.3M Sell
32,363
-782
-2% -$57.5K 0.2% 74
2018
Q1
$2.44M Buy
33,145
+4,274
+15% +$315K 0.21% 66
2017
Q4
$2.11M Sell
28,871
-2,202
-7% -$159K 0.62% 28
2017
Q3
$2.21M Sell
31,073
-6,216
-17% -$438K 0.19% 70
2017
Q2
$2.58M Sell
37,289
-191,693
-84% -$13.2M 0.22% 66
2017
Q1
$3.1M Sell
228,982
-64,451
-22% -$4.13M 0.26% 63
2016
Q4
$5.55M Buy
293,433
+242,696
+478% +$15.3M 0.5% 31
2016
Q3
$3.43M Sell
50,737
-5,834
-10% -$392K 0.34% 41
2016
Q2
$3.76M Buy
56,571
+3,034
+6% +$203K 0.35% 46
2016
Q1
$3.56M Buy
53,537
+31,514
+143% +$2.01M 0.34% 45
2015
Q4
$1.43M Buy
22,023
+12,877
+141% +$839K 0.16% 39
2015
Q3
$571K Buy
9,146
+52
+0.6% +$3.38K 0.05% 66
2015
Q2
$594K Buy
+9,094
New +$617K 0.06% 65

Other funds holding EFAV

Aspiriant LLC's EFAV Position: Q2 2026 in Review

Aspiriant LLC reduced its iShares MSCI EAFE Min Vol Factor ETF (EFAV) stake by 0.54% in Q2 2026, selling an estimated $27.1K and leaving 55,558 shares worth $4.87M. The position accounts for 0.12% of the portfolio, ranked #75.

Aspiriant LLC first reported a position in EFAV in Q2 2015 and has held it in 45 quarters since. The position peaked at $32.9M in Q3 2022. 529 funds tracked by Wall St. Rank hold EFAV as of Q2 2026.

  • Aspiriant LLC held 55,558 shares of iShares MSCI EAFE Min Vol Factor ETF worth $4.87M as of Q2 2026.
  • Aspiriant LLC sold 299 iShares MSCI EAFE Min Vol Factor ETF shares in Q2 2026, an estimated $27.1K.
  • iShares MSCI EAFE Min Vol Factor ETF made up 0.12% of Aspiriant LLC's portfolio in Q2 2026, its #75 holding.
  • Aspiriant LLC first reported a position in iShares MSCI EAFE Min Vol Factor ETF in Q2 2015 and has held it in 45 quarters since.
  • Aspiriant LLC's iShares MSCI EAFE Min Vol Factor ETF position peaked at $32.9M in Q3 2022.
  • 529 funds tracked by Wall St. Rank held iShares MSCI EAFE Min Vol Factor ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.